December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MasterBrand, Inc. Common Stock (NY:MBC)

9.400 -0.190 (-1.98%)
Streaming Delayed Price Updated: 9:47 AM EST, Mar 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MasterBrand, Inc. Common Stock

< Previous 1 2 3 4 Next >
News headline image
12 Industrials Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Industrials Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
MasterBrand Reports Fourth Quarter and Full Year 2022 Financial Results
From MasterBrand, Inc.
Via Business Wire
News headline image
MasterBrand to Announce Fourth Quarter and Full Year 2022 Results on March 7
From MasterBrand, Inc.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  During Friday's trading, 71 companies set new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022 ↗
 
Via Benzinga
News headline image
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. 
Via Benzinga
News headline image
Melco, Ardelyx And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Cosmos Health Inc. (NASDAQ: COSM) shares dipped 37.7% to $14.33 in... 
Via Benzinga
News headline image
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket ↗
Gainers AIM ImmunoTech Inc. (NYSE: AIM) shares rose 82.4% to $0.62 in pre-market trading. AIM ImmunoTech recently reported safety, tolerability and biological activity data for intranasal ampligen in... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.